文献速递哮喘

反复温度变化通过TRPA1加重哮喘小鼠气道炎症

Repeated exposure to temperature variation exacerbates airway inflammation through TRPA1 in a mouse model of asthma.
PubMed 文献 · Respirology · 2018-11-15

该研究在BALB/c小鼠哮喘模型中观察不同温度条件(恒温26°C、26°C/18°C循环、26°C/10°C循环)对气道炎症的影响,并探讨TRPA1的作用。结果显示最大温差(16°C)加重OVA诱导的气道炎症、增加血清总IgE和IgG1、BALF炎症细胞和细胞因子,并加重气道高反应性;TRPA1表达上调,而TRPA1阻断剂HC030031可减轻上述病理特征。结论认为反复温度变化加重实验性哮喘,且TRPA1介导该温度依赖性炎症效应。

要点

  • 反复温度变化(尤其最大温差16°C)加重哮喘小鼠气道炎症和气道高反应性。
  • 温度变化上调TRPA1表达,TRPA1阻断剂HC030031可减轻哮喘样病理特征。
  • TRPA1介导温度变化相关的气道炎症效应。

核心结论

  • 反复暴露于温度变化可加重实验性哮喘,且TRPA1介导该温度依赖性炎症效应。

研究设计与样本

  • BALB/c小鼠哮喘模型,21天内暴露于恒温26°C、26°C/18°C循环或26°C/10°C循环,并接受卵清蛋白(OVA)致敏和激发。
  • 使用选择性TRPA1通道阻断剂HC030031探讨TRPA1在哮喘气道中的作用。

主要发现

  • 温度变化尤其最大温差(16°C)加重OVA诱导小鼠气道炎症,增加血清总IgE和IgG1水平、BALF炎症细胞和细胞因子。
  • 组织病理学和肺功能分析证实反复暴露于极冷和变化温度加重气道高反应性(AHR)。
  • 最大温度变化(26°C/10°C循环)下免疫组化显示TRPA1表达显著上调。
  • 给予HC030031成功抑制TRPA1表达,从而减轻哮喘样病理特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Studies from epidemiology suggest that ambient temperature is one of the underlying triggers and potential causes of asthma. The aim of this study was to examine the impact and the molecular mechanism of temperature-invoked airway inflammation using an experimental model of asthma in BALB/c mice. METHODS: Mice were exposed to different temperature conditions (steady 26°C, 26°C/18°C cycle, 26°C/10°C cycle) and received sensitization and challenge of ovalbumin (OVA) during a 21-day period. HC030031, a selective transient receptor potential A1 (TRPA1) channel blocker, was used to investigate the underlying mechanism of TRPA1 in 'asthmatic' airways. After the final OVA challenge, in vivo lung function was measured, and bronchoalveolar lavage fluid (BALF) and pulmonary inflammation were assessed. RESULTS: The temperature variations, especially the largest temperature difference (16°C), exacerbated airway inflammation in OVA-induced mice, increasing the levels of serum total-IgE (immunoglobulin E) and IgG1, inflammatory cells and cytokines in BALF. Analysis of histopathological changes and lung function verified that repeated exposure to very cold and changed temperatures aggravated airway hyperresponsiveness (AHR). Significant upregulation of TRPA1 expression was revealed by immunohistochemistry in the presence of the largest temperature variation (26°C/10°C cycle), while administration of HC030031 successfully inhibited TRPA1 expression, thus attenuating the asthma-like pathological features. CONCLUSION: Repeated exposure to temperature variation exacerbated experimental 'asthma' and TRPA1 mediated this temperature-dependent inflammatory effect.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Du C, Kang J, Yu W, et al. Repeated exposure to temperature variation exacerbates airway inflammation through TRPA1 in a mouse model of asthma. Respirology. 2018. PMID: 30440113. doi:10.1111/resp.13433

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。